Endometrial neoplasm and Weakness
Summary:
Weakness is found among people with Endometrial neoplasm, especially for people who are female, 60+ old.
The study analyzes which people have Weakness with Endometrial neoplasm. It is created by eHealthMe based on reports of 27 people who have Endometrial neoplasm from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Endometrial neoplasm?
Endometrial neoplasm (tumour of uterus wall) is found to be associated with 19 drugs and 50 conditions by eHealthMe. Check the latest studies of Endometrial neoplasm.
What is Weakness?
Weakness is found to be associated with 3,638 drugs and 6,618 conditions by eHealthMe. Check the latest studies of Weakness.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
27 people who have Endometrial Neoplasm and Weakness are studied.

Gender of people who have Endometrial Neoplasm and experienced Weakness *:
- female: 100 %
- male: 0.0 %
Age of people who have Endometrial Neoplasm and experienced Weakness *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 14.29 %
- 50-59: 9.52 %
- 60+: 76.19 %
Common co-existing conditions for these people *:
- Endometrial Cancer: 5 people, 18.52%
- Ovarian Cancer (cancer of ovary): 2 people, 7.41%
- Ovarian Cancer Metastatic (cancer of ovary spreads to other organ or parts): 1 person, 3.70%
- Malignant Pleural Effusion (a condition in which cancer causes an abnormal amount of fluid to collect between the thin layers of tissue lining of lung): 1 person, 3.70%
- Asthma: 1 person, 3.70%
Common drugs taken by these people *:
- Lenvima: 15 people, 55.56%
- Keytruda: 14 people, 51.85%
- Vitamin B12: 3 people, 11.11%
- Zofran: 3 people, 11.11%
- Rubraca: 3 people, 11.11%
- Synthroid: 3 people, 11.11%
- Multivitamin: 3 people, 11.11%
- Hydrochlorothiazide: 3 people, 11.11%
- Vitamins: 2 people, 7.41%
- Diazepam: 2 people, 7.41%
Common symptoms for these people *:
- Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 17 people, 62.96%
- Fatigue (feeling of tiredness): 17 people, 62.96%
- Nausea (feeling of having an urge to vomit): 14 people, 51.85%
- Weight Decreased: 12 people, 44.44%
- Diarrhea: 11 people, 40.74%
- High Blood Pressure: 10 people, 37.04%
- Nausea And Vomiting: 10 people, 37.04%
- Dehydration (dryness resulting from the removal of water): 7 people, 25.93%
- Constipation: 6 people, 22.22%
- Dizziness: 6 people, 22.22%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Weakness?
- Check whether Weakness is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Endometrial neoplasm (480 reports)
- Weakness (586,877 reports)
All the drugs that are associated with Weakness:
- Weakness (3,638 drugs)
All the conditions that are associated with Weakness:
- Weakness (6,618 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Weakness and Endometrial neoplasm, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Sular cause Nephrogenic Systemic Fibrosis? - now
- Could Pioglitazone Hydrochloride cause Renal Failure Aggravated? - 3 seconds ago
- Could Topiramate cause Nausea And Vomiting? - 6 seconds ago
- Could Doral cause Thrombocytopenia Aggravated? - 11 seconds ago
- Could Sudafed cause Speech Impairment (Adult)? - 13 seconds ago
- Drug interactions of Lipitor and Mounjaro - 17 seconds ago
- Could Intron A cause Hoarseness Or Changing Voice? - 20 seconds ago
- Could Donepezil cause Aggression? - 21 seconds ago
- Could Labetalol Hydrochloride cause Osteoarthritis? - 21 seconds ago
- Could Suboxone cause Loose Tooth? - 23 seconds ago